Total investments received (USD): 113.6m
Round value (USD): 5.69m
Company: Aprea Therapeutics
Industry:
Biotech
Health services





Belgium
Austria
Germany
Switzerland
Denmark
Finland
Iceland
Latvia
Lithuania
Norway
France
Ireland
Italy
Portugal
Spain